Fasting and Inflammation

Anti-inflammatory effects are among the most-cited claims for intermittent fasting. The mechanism is real — fasting modulates several inflammatory pathways measurably — and a growing body of research examines specific autoimmune and inflammatory conditions. But the marketing has run far ahead of the evidence, and the picture is more nuanced than “fasting cures inflammation.”

This guide covers what fasting actually does to inflammation, what the evidence shows for specific conditions (rheumatoid arthritis, psoriasis, MS, IBD), the mechanisms involved, and the realistic expectations for someone with autoimmune disease considering fasting.

How Fasting Affects Inflammation

Several mechanisms link fasting to reduced inflammation:

  • Reduced inflammatory cytokines. Sustained fasting practice reduces circulating IL-6, TNF-alpha, and CRP in many studies. The effect is modest but consistent.
  • Increased autophagy. Damaged cellular components (including misfolded proteins involved in some autoimmune processes) are cleared more efficiently.
  • Beta-hydroxybutyrate effects. The dominant fasting ketone directly inhibits the NLRP3 inflammasome — a key driver of inflammation in conditions ranging from gout to atherosclerosis.
  • Microbiome shifts. Fasting periods favour bacterial populations associated with reduced systemic inflammation.
  • Reduced visceral fat. Visceral fat is itself an inflammatory tissue; reducing it reduces background inflammation.
  • Reduced AGEs and oxidative stress. Fewer post-meal glucose excursions means less advanced glycation end product formation.

These mechanisms are well-supported. The clinical translation to specific autoimmune conditions is more variable.

Rheumatoid Arthritis

RA has the longest research history with fasting. Several small clinical trials dating back to the 1980s show that prolonged fasting (7-10 days, water or vegetable juice based) followed by a vegetarian or vegan diet produces meaningful symptom reduction in RA patients — joint pain, stiffness, swelling, inflammatory markers all improve.

The benefits typically require:

  • An initial extended fast (medically supervised in the studied protocols)
  • Sustained dietary change post-fast (typically plant-based, low in arachidonic acid sources)
  • Continuation of standard RA medication during the process

Modest intermittent fasting alone has weaker evidence for RA than the full protocol. The effects of 16:8 alone on RA are less studied and less consistent than the extended-fast-plus-dietary-change approach.

Psoriasis

Limited but interesting data. Several small studies and Ramadan-fasting observational research suggest:

  • Modest reduction in psoriasis severity (PASI score) during sustained fasting practice
  • Improvement in associated metabolic syndrome markers (psoriasis is heavily metabolic)
  • Possible reduction in arthritic symptoms in psoriatic arthritis patients

Mechanism likely involves both direct anti-inflammatory effects and indirect benefits via weight loss and improved insulin sensitivity. Results are modest, not curative.

Multiple Sclerosis

MS has emerging research interest in fasting and ketogenic approaches. Available evidence:

  • Animal models of MS (EAE) show consistent benefit from fasting and fasting-mimicking diet protocols
  • Small human pilot studies of MS patients on intermittent fasting or FMD show improvement in some symptom domains and quality-of-life measures
  • Larger trials are underway

The mechanism likely involves both direct neuroprotection from ketones and immune-modulating effects. The evidence is promising but not yet definitive enough for clinical recommendation. MS patients considering fasting should discuss with their neurologist; coordination with disease-modifying therapy matters.

IBD (Crohn’s, Ulcerative Colitis)

Mixed picture. Some patients in remission report symptom benefit from intermittent fasting; others find it triggers flares. Specific considerations:

  • Fasting during active flares is generally not recommended — caloric and nutrient demands rise during inflammation
  • Fasting during remission may be tolerable and possibly beneficial
  • The fasting-mimicking diet has small but interesting trials in IBD specifically
  • Adequate caloric intake during eating windows matters more for IBD patients than the general population

This is firmly in the “discuss with your gastroenterologist” category. See our gut health guide.

Hashimoto’s

Moderate intermittent fasting is generally well tolerated by Hashimoto’s patients on stable thyroid replacement. Antibody levels (TPO, Tg) sometimes improve modestly with sustained fasting practice; symptoms (fatigue, brain fog, joint aches) often improve via metabolic mechanisms. See our thyroid guide for detail.

General Autoimmune Considerations

Common principles across autoimmune conditions:

  • Don’t replace established medication with fasting. Fasting may eventually reduce medication need in some cases, but only under medical supervision.
  • Don’t fast through active flares. Acute disease activity increases caloric and nutrient needs.
  • Track symptoms carefully. Autoimmune disease activity fluctuates; attribution of changes to fasting requires careful tracking.
  • Adequate calories matter more than for healthy adults. Sustained under-eating amplifies fatigue and may worsen disease activity in some conditions.
  • Sleep, stress, and gentle exercise matter alongside fasting. Autoimmune disease responds to the broader pattern, not the protocol alone.
  • Adaptation may be more disruptive. Plan to start gentle (12:12 to 14:10) and build slowly.

Practical Protocols

Conservative starting point: 14:10

Eat 9 AM – 7 PM. Easy to maintain. Modest metabolic effects without aggressive disruption.

Moderate: 16:8 with morning eating window

Eat 8 AM – 4 PM or 10 AM – 6 PM. Stronger evidence base for inflammation reduction. Suitable for most people in remission.

Targeted: Periodic FMD-style cycles

5-day fasting-mimicking diet protocols once monthly or quarterly, with normal eating in between. The most-studied approach for some autoimmune conditions. Requires deliberate planning. See our FMD guide.

Avoid: Frequent extended fasts during active disease

Multi-day fasts during flares amplify catabolism and stress. Save for remission periods, with medical input.

Frequently Asked Questions

Will fasting reduce my CRP?

Often yes, modestly. Sustained practice typically reduces hs-CRP by 10-30% in people with elevated baseline values. Larger reductions occur with combined weight loss.

Can fasting cure autoimmune disease?

No. Fasting may modulate disease activity and improve symptoms; it does not cure underlying autoimmunity. Maintenance practice is required to maintain benefit.

Should I stop my biologic medication if fasting helps?

Never without rheumatologist input. Even if symptoms improve, the underlying disease process continues. Medication adjustments must be physician-managed.

Why does fasting feel like it helps inflammation immediately?

Acute fasting periods reduce post-meal inflammatory responses and gut antigen exposure. The acute relief is real but usually doesn’t represent disease modification — the longer-term benefits develop over months.

Is autophagy from fasting actually reducing inflammation?

Plausibly yes, in animal models and mechanistic studies. The translation to specific human autoimmune outcomes is still being studied. The current evidence supports the mechanism but doesn’t fully validate the “autophagy cures autoimmunity” framing common in popular content.

Which autoimmune conditions have the best fasting evidence?

Rheumatoid arthritis (oldest evidence base), MS (emerging), and IBD (mixed but interesting). For most others, evidence is anecdotal or extrapolated from inflammation mechanisms generally.

The Bottom Line

Fasting genuinely modulates inflammation through multiple mechanisms, and the effect is real for many people with autoimmune and inflammatory conditions. The clinical translation varies by condition: rheumatoid arthritis has the strongest evidence (with extended fasts plus dietary change), psoriasis and MS have promising emerging research, IBD is mixed and individual. For all autoimmune conditions, fasting is an adjunct to established medical management, not a replacement. Start gentle, track symptoms, coordinate with your specialist, and don’t expect miracles — expect modest improvements that compound over months.

Related Reading